Biocon Biologics receives U.S. FDA approval for Jobevne

JOBEVNE, a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to the reference product Avastin (bevacizumab).

Apr 10, 2025 - 14:30
 0
Biocon Biologics receives U.S. FDA approval for Jobevne
JOBEVNE, a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to the reference product Avastin (bevacizumab).

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow